4:36

Alicia Luers from Emory Pharma walks through their NMR capabilities: a Bruker 400 MHz instrument that can observe multiple nuclei and run from -130 to +130 °C. They use 1D and 2D NMR workflows plus NOE experiments to assign structure and stereochemistry, offering full characterization for FDA and regulatory submissions.

Questions this video answers

Bruker 400 MHz NMR

-130 to +130 °C

Proton (1H), carbon (13C), phosphorus (31P), chlorine (e.g., 35Cl), fluorine (19F), silicon (29Si)

Chapters

More from Dr.

youtube.com

Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health

11mo ago
youtube.com

Robert Lustig, MD: Everything You Know About Obesity Is Wrong

11mo ago
youtube.com

What is the latest on Ozempic and Ozempic like drugs #ozempic #glp1

11mo ago
youtube.com

Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It

11mo ago
youtu.be

Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.

11mo ago
youtube.com

The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig

11mo ago
youtube.com

Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet

1y ago
youtube.com

Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome

1y ago
youtube.com

Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose

1y ago
youtube.com

Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance

1y ago
youtube.com

Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet

1y ago
See all content